- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Platypus Technologies, LLC a life sciences nanotechnology company has been awarded a Phase I Small Business Innovation Research (SBIR) grant for $600,000 from the National Institute of Allergy and Infectious Diseases. The funds will be used to develop hepatitis screening assays that can simultaneously detect multiple proteins from a single sample. The assays will utilize the Company's proprietary liquid crystal-based technology for rapid detection of molecular interactions. Platypus Technologies has received over $15.5 million in federal funding to develop nanotechnology products for the physical and life sciences.
About Platypus Technologies, LLC
Platypus Technologies, LLC develops innovative products for the analytic and life sciences based upon the application of nanotechnologies. Utilizing recent advances in nanoscale and material science, the company provides advanced tools for use in proteomics, cell-based studies, and environmental monitoring. The company is developing a range of products that derive from a proprietary platform technology utilizing liquid crystals for the rapid detection of molecular interactions. In August 2007, the Company launched its Oris™ Cell Migration Assay. Platypus has 21 employees and is located in the Fitchburg Technology Campus.
For more information, please click here
Platypus Technologies, LLC
5520 Nobel Drive, Suite 100
Madison, WI 53711
Minnie Gupta, Director of Marketing
Copyright © Platypus Technologies, LLCIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|